1
510
R. Zheng et al.
2
. (a) Atwal, K. S.; Rovnyak, G. C.; Kinball, S. D.; Floyd, D. M.; Moreland, S.;
Swanson, B. N.; Gougoutas, J. Z.; Schwartz, J.; Smillie, K. M.; Mallay, M. F.
Dihydropyrimidine calcium channel blockers, II: 3-Substituted-4-ary-1,4-
dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydro-
pyridines. J. Med. Chem. 1990, 33, 2629; (b) Ronyak, G. C.; Kimball, S. D.;
Beyer, B.; Cucinotta, G.; Dimarco, J. D.; Gougoutas, J. Z.; Hedberg, A.;
Mallay, M.; McCarthy, J. P.; Zheng, R.; Moreland, S. Calcium entry blockers
and activators: Conformational and structural determinants of dihydropyrimidine
calcium channel modulators. J. Med. Chem. 1995, 38, 119.
3
. Kappe, C. O. Recent advances in the Biginelli dihydropyrimidine synthesis: New
tricks from an old dog. Acc. Chem. Res. 2002, 33, 879.
4
. (a) Nagarathnam, D.; Wong, W. C.; Miao, S. W.; Patance, M. A.; Gluchowski, C.
Dihydropyrimidines and thereof. PCT Int. Appl. WO 97 17, 969, 1997;
(
b) Sidler, D. R.; Larsen, R. D.; Chartrain, M.; Ikemoto, N.; Roberg, C. M.;
Taylor, C. S.; Li, W.; Bills, G. F. Alpha 1a adrenergic receptor antagonist. PCT
Int. Appl. WO 99 07, 695, 1999.
5
6
. Bruce, M. A.; Pointdexter, G. S.; Johnson, G. P. Dihydropyrimidone derivatives as
NPY antagonists. PCT Int. Appl. WO 98 33, 791, 1998.
. Kappe, C. O.; Uray, G.; Verdino, P.; Shishkin, O. V. Synthesis and reactions of
Biginelli compounds, part 19—X-ray structure, conformational analysis, enantio-
separation, and determination of absolute configuration of themitotic kinesin Eg5
inhibitor monastrol. Tetrahedron 2000, 65, 1859.
7
. Deres, K.; Schroder, C. H.; Paessens, A.; Goldmann, S.; Hecker, H. J.; Weber, O.;
Kramer, T.; Niewohner, U.; Pleiss, U.; Stoltefuss, J.; Graef, E.; Koletzki, D.;
Masantschek, R. N. A.; Reimann, A.; Jaeger, R.; Gross, R.; Beckermann, B.;
Schlemmer, K. H.; Haebich, D.; Rubsamen-Waigmann, H. Inhibition of
hepatitis B virus replication by drug-induced depletion of nucleocapsids.
Science 2003, 299, 893.
8
. (a) Snider, B. B.; Shi, Z. Biornimetic synthesis of (+)-crambines A, B, C1, and
C2: Revision of the structure of crambines B and C1. J. Org. Chem. 1993, 58,
3
828; (b) Patil, A. D.; Kumar, N. V.; Kokke, W. C.; Bean, M. F.; Freyer, A. J.;
DeBrosse, C.; Mai, S.; Truneh, A.; Gaulkner, D. J.; Carts, B.; Breen, A. L.;
Hertzberg, R. P.; Johnson, R. K.; Westly, J. W.; Potts, B. C. M. Novel alkaloids
from the sponge Batzella sp.: Inhibitors of HIV gp120-human CD4 binding.
J. Org. Chem. 1995, 60, 1182.
9
. Biginelli, P. Aldehyde–urea derivatives of aceto- and oxaloacetic acids. Gazz.
Chim. Ital. 1893, 23, 360.
1
0. Atwal, K. S.; Rovnyak, G. C.; O’Reilly, B. C.; Schwartz, J. Substituted 1,4-dihy-
dropyrimidines. 3. Synthesis of selectively functionalized 2-hetero-1,4-dihydro-
pyrimidines. J. Org. Chem. 1989, 54, 5898.
1
1. (a) Atwal, K. S.; O’Reilly, B. C.; Gougoutas, J. Z.; Malley, M. F. Synthesis of sub-
stituted 1,2,3,4-tetrahydro-6-methyl-2-thioxo-5-pyrimidinecarboxylic acid esters.
Heterocycles 1987, 26, 1189; (b) Barluenga, J.; Tomas, M.; Rubio, V.;
Gotor, V. Simple and regioselective synthesis of N-substituted pyrimidine-
2
(1H)-ones and -thiones. J. Chem. Commun. 1979, 675.
1
2. (a) Hu, E. H.; Sidler, D. R.; Dolling, U. H. Unprecedented catalytic three-
component one-pot condensation reaction: An efficient synthesis of 5-alkoxycar-
bonyl-4-ary-3,4-dihydropyrimidin-2(1H)-ones. J. Org. Chem. 1998, 63, 3454;
(
3
b) Lu, J.; Bai, Y. J.; Wang, Z. J.; Yang, B. Q.; Ma, H. R. One-pot synthesis of
,4-dihydropyrimidin-2(1H)-ones using lanthanum chloride as a catalyst. Tetrahe-
dron Lett. 2000, 41, 9075; (c) Kumar, K. A.; Kasthuraiah, M.; Reddy, C. S.;